Polymyalgia rheumatica
Authors:
Abstract
Polymyalgia rheumatica is the most common inflammatory rheumatic disease in elderly white people, and it is a common indication for long term treatment with glucocorticosteroids in patients based in the community.1 2 Although the symptoms are very characteristic, several other autoimmune, infectious, endocrine, and malignant disorders can present with similar symptoms. The course of disease is heterogeneous and unpredictable, and giant cell arteritis is seen in about 30% of patients.3 Glucocorticosteroids rapidly improve disease symptoms in most patients but may have serious side effects. This review looks at the current understanding of diagnosis and the management of polymyalgia rheumatica. #### Sources and selection criteria We searched PubMed, Embase, Scopus, Premedline, and National Institutes for Health Clinical Trials publications from 2000 to 2007 for strategies for the diagnosis and management of polymyalgia rheumatica. We found no Cochrane reviews on the subject. Polymyalgia rheumatica is seen mainly in people of north European ancestry, although it can occur in any ethnic group. It is almost never seen in people under the age of 50, and its prevalence increases with increasing age. The average age of onset is just over 70, and 75% of patients are women. The incidence of the disease in patients over 50 is about 100 per 100 000.1 2 #### Summary points The cause of polymyalgia rheumatica is unknown, although both …Keywords
This publication has 22 references indexed in Scilit:
- Treatment of refractory polymyalgia rheumatica with etanercept: An open pilot studyArthritis Care & Research, 2007
- Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001Annals of the Rheumatic Diseases, 2006
- EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)Annals of the Rheumatic Diseases, 2003
- Polymyalgia Rheumatica and Giant-Cell ArteritisNew England Journal of Medicine, 2002
- Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumaticaArthritis & Rheumatism, 1997
- The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.Annals of the Rheumatic Diseases, 1993
- Treatment of Polymyalgia Rheumatica: Lower Initial DoseRheumatology, 1991
- Relationship between Rheumatological Diseases of Man, Pet Dogs and their VirusesRheumatology, 1991
- Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.Annals of the Rheumatic Diseases, 1989
- Prognosis and management of polymyalgia rheumatica.Annals of the Rheumatic Diseases, 1981